Loading the section…
Company reports as filed with the U.S. Securities and Exchange Commission.
| Metric | 31/03/2026 | 31/12/2025 | 30/09/2025 | 31/03/2025 | 31/12/2024 | 30/09/2024 |
|---|---|---|---|---|---|---|
| Revenue | 407M | 415M | 396M | 358M | 363M | 358M |
| Cost of revenue | 75M | 84M | 77M | 67M | 67M | 65M |
| Gross profit | 332M | 331M | 319M | 291M | 296M | 294M |
| Research and development | 74M | 83M | 80M | 87M | 85M | 79M |
| Selling, general and administrative | 72M | 79M | 77M | 74M | 71M | 67M |
| Operating expenses | 332M | 349M | 339M | 320M | 318M | 301M |
| Operating income | −399,000 | −18M | −21M | −29M | −22M | −8M |
| Pre-tax income | 15M | −2M | −3M | −10M | 34M | 10M |
| Income tax | 2M | 522,000 | 149,000 | 1M | 45,000 | 1M |
| Net income | 13M | −3M | −3M | −12M | 34M | 9M |
| Earnings per share | 0.13 | −0.03 | −0.03 | −0.11 | 0.33 | 0.08 |
| Earnings per share, diluted | 0.12 | −0.03 | −0.03 | −0.11 | −0.06 | 0.08 |
| Weighted average shares | 99M | 101M | 102M | 102M | 103M | 106M |
| Weighted average shares, diluted | 113M | 101M | 102M | 102M | 104M | 107M |
| Metric | 31/03/2026 | 31/12/2025 | 30/09/2025 | 30/06/2025 | 31/03/2025 | 31/12/2024 | 30/09/2024 | 30/06/2024 |
|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 995M | 1.09B | 1.10B | 1.04B | 1.05B | 1.57B | 853M | 986M |
| Receivables | 32M | 41M | 32M |
| Metric | 31/03/2026 | 31/12/2025 | 30/09/2025 | 31/03/2025 | 31/12/2024 | 30/09/2024 |
|---|---|---|---|---|---|---|
| Operating cash flow | — | — | 97M | — | — | 89M |
| Depreciation and amortisation | 8M | 8M | 8M | 8M |
Amounts in USD unless stated otherwise. Data: US exchange trading and company filings with the regulator
| 32M |
| 27M |
| 29M |
| 32M |
| 28M |
| Current assets | 7.28B | 7.33B | 7.33B | 7.24B | 6.80B | 6.84B | 6.20B | 6.31B |
| Property, plant and equipment | 139M | 127M | 129M | 117M | 105M | 94M | 90M | 88M |
| Goodwill | 2.40B | 2.40B | 2.40B | 2.40B | 2.40B | 2.40B | 2.40B | 2.40B |
| Total assets | 10.08B | 10.13B | 10.15B | 10.06B | 9.63B | 9.67B | 9.05B | 9.18B |
| Current liabilities | 4.39B | 4.43B | 4.38B | 4.59B | 4.02B | 4.12B | 4.06B | 4.06B |
| Total liabilities | 6.28B | 6.32B | 6.27B | 6.15B | 5.76B | 5.86B | 5.03B | 5.04B |
| Equity | 3.80B | 3.81B | 3.88B | 3.91B | 3.87B | 3.81B | 4.01B | 4.13B |
| Shares outstanding | — | — | — | 103M | — | — | — | 107M |
| Shares issued | — | — | — | 103M | — | — | — | 107M |
| 8M |
| 9M |
| Share-based compensation | — | — | 59M | — | — | 55M |
| Capital expenditure | — | — | 1M | — | — | 17,000 |
| Investing cash flow | — | — | −109M | — | — | −140M |
| Share buybacks | — | — | 83M | — | — | 200M |
| Financing cash flow | — | — | 1M | — | — | −105M |